364.Leadership: INSIGHTEC CCO Jake Ghannam On Scaling a Breakthrough Neurosurgery Company

In this episode, Omar Khateeb sits down with Jake Ghannam, Executive Vice President and Chief Commercial Officer at INSIGHTEC, to discuss how a breakthrough neurosurgery technology is redefining treatment for patients with severe tremors and neurological disorders.Jake explains how INSIGHTEC is building a global platform around incisionless brain surgery and what it takes to commercialize a complex medical innovation in highly regulated healthcare markets. He also shares lessons from his career journey, from selling medical devices in operating rooms to leading the commercial strategy for one of the most innovative companies in medtech.They explore the realities of scaling global medtech companies, the importance of talent and leadership in healthcare innovation, and why focus and execution are critical when bringing life saving technologies to market.If you are interested in medtech innovation, commercialization strategy, and the future of neurosurgery, this episode offers deep insight into how groundbreaking technologies become real world solutions for patients.Episode Breakdown:00:00 Incisionless Brain Surgery That Stops Tremors01:05 Introduction to the Episode and Guest08:15 Seeing Patients’ Tremors Stop in Real Time10:20 The Origin Story of Insightec13:05 Why This Technology Is a Neurosurgery Moonshot15:10 How Focused Ultrasound Works Inside the Brain17:40 The Science of Delivering Acoustic Energy Safely35:00 Why This Technology Is Changing Neurosurgery38:05 Challenges of Bringing New MedTech to Market41:00 FDA Approvals and Regulatory Milestones43:45 Adoption by Hospitals and Neurosurgeons46:30 The Future of Focused Ultrasound in Medicine49:15 Expanding Treatments Beyond Movement Disorders58:00 The Long-Term Vision for Insightec01:01:00 Advice for Founders Building Medical Technology01:03:20 Final Thoughts on the Future of Neurosurgery01:05:10 Outro and Where to Follow the ShowAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech  #medtechinnovation #parkinsonstreatment #neurosurgery #healthcareinnovation